Capivasertib is an AKT inhibitor designed for the treatment of HR /HER2breast cancer with PIK3CA/AKT1/PTEN alterations. It works by stopping AKT signaling, a big deal in how cancers grow and keep going. You can get it as pills, and there are two sizes: 200 mg and 400 mg.
Doctors usually say to take 400 mg, twice a day, and then take 3 days off after 4 days of taking it. Each bottle has 64 tablets, enough for one full cycle of treatment.
